BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL
Publication
, Conference
Sandhu, RK; Ezekowitz, J; Andersson, U; Alexander, J; Granger, C; Halvorsen, S; Hanna, M; Hijazi, Z; Jansky, P; Lopes, R; Wallentin, L
Published in: Journal of the American College of Cardiology
March 2015
Duke Scholars
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
March 2015
Volume
65
Issue
10
Start / End Page
A284 / A284
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sandhu, R. K., Ezekowitz, J., Andersson, U., Alexander, J., Granger, C., Halvorsen, S., … Wallentin, L. (2015). BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL. In Journal of the American College of Cardiology (Vol. 65, pp. A284–A284). Elsevier BV. https://doi.org/10.1016/s0735-1097(15)60284-4
Sandhu, Roopinder K., Justin Ezekowitz, Ulrika Andersson, John Alexander, Christopher Granger, Sigrun Halvorsen, Michael Hanna, et al. “BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL.” In Journal of the American College of Cardiology, 65:A284–A284. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60284-4.
Sandhu RK, Ezekowitz J, Andersson U, Alexander J, Granger C, Halvorsen S, et al. BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL. In: Journal of the American College of Cardiology. Elsevier BV; 2015. p. A284–A284.
Sandhu, Roopinder K., et al. “BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL.” Journal of the American College of Cardiology, vol. 65, no. 10, Elsevier BV, 2015, pp. A284–A284. Crossref, doi:10.1016/s0735-1097(15)60284-4.
Sandhu RK, Ezekowitz J, Andersson U, Alexander J, Granger C, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes R, Wallentin L. BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL. Journal of the American College of Cardiology. Elsevier BV; 2015. p. A284–A284.
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
March 2015
Volume
65
Issue
10
Start / End Page
A284 / A284
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology